← back to search

Sumitra Muralidhar

Universitas Pembangunan Nasional Veteran Yogyakarta · SE
Area of research
Genetics · Epidemiology
Research interest
Research interests include Genetic Associations and Epidemiology, Cytomegalovirus and herpesvirus research, COVID-19 Clinical Research Studies, and Viral-associated cancers and disorders.
h-index
37
citations
6,806
works
124
NIH funding
primary concept
Medicine
email

Recent publications

Biological insights into schizophrenia from ancestrally diverse populations.
2026cited by 1position: contributordoi
Leveraging Large-Scale Biobanks for Therapeutic Target Discovery
medRxiv 2025cited by 4position: middledoi
Primary care providers’ perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study
Genetics in Medicine 2025cited by 1position: middledoi
Integrative Proteome- and Phenome-Wide Assessment Uncovers Causal Protein Drivers and Drug Targets for Heterogeneous Kidney Diseases
2025cited by 0position: contributordoi
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Science 2024cited by 339position: middledoi
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk.
2024cited by 16position: contributordoi
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder
Molecular Psychiatry 2024cited by 15position: middledoi
Characterization of Post–COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study
Online Journal of Public Health Informatics 2024cited by 13position: middledoi
Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.
2024cited by 10position: contributordoi
Centralized Interactive Phenomics Resource: an integrated online phenomics knowledgebase for health data users
Journal of the American Medical Informatics Association 2024cited by 9position: middledoi
Multi-ancestry genome-wide association meta-analysis of mosaic loss of chromosome Y in the Million Veteran Program identifies 240 novel loci
medRxiv 2024cited by 5position: middledoi
Biological Insights from Schizophrenia-associated Loci in Ancestral Populations
medRxiv 2024cited by 4position: middledoi
Multi-ancestry genome-wide association meta-analysis of mosaic loss of chromosome Y in the Million Veteran Program identifies 240 novel loci
2024cited by 2position: contributordoi
Providers' use of pharmacogenetic testing to inform opioid prescribing among veterans.
2024cited by 0position: contributordoi
Multi-ancestry meta-analyses of lung cancer in the Million Veteran Program reveal novel risk loci and elucidate smoking-independent genetic risk
2024cited by 0position: contributordoi
Potential pitfalls in the use of real-world data for studying long COVID
Nature Medicine 2023cited by 40position: middledoi
Framework of the Centralized Interactive Phenomics Resource (CIPHER) standard for electronic health data-based phenomics knowledgebase
Journal of the American Medical Informatics Association 2023cited by 25position: middledoi
Characterization of Post–COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study (Preprint)
2023cited by 0position: contributordoi
Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder
2023cited by 0position: contributordoi
Characterization of Long COVID Definitions and Clinical Coding Practices
2023cited by 0position: contributordoi
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
Nature Genetics 2022cited by 188position: middledoi
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder
JAMA 2022cited by 178position: middledoi
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
Circulation 2022cited by 56position: middledoi
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System
JAMA Psychiatry 2022cited by 44position: middledoi
Genome-Wide Investigation of Maximum Habitual Alcohol Intake in US Veterans in Relation to Alcohol Consumption Traits and Alcohol Use Disorder
JAMA Network Open 2022cited by 43position: middledoi
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell Trait
JAMA Internal Medicine 2022cited by 23position: middledoi
Impact of Coronavirus Disease 2019 (COVID-19) Severity on Long-term Events in United States Veterans Using the Veterans Affairs Severity Index for COVID-19 (VASIC)
The Journal of Infectious Diseases 2022cited by 14position: middledoi
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Nature Medicine 2021cited by 245position: middledoi
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
Nature Communications 2021cited by 126position: middledoi
Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
PLoS ONE 2021cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2023–2026)Rachel Ramoni · Veterans Health Administration7 papers (2021–2024)Kelly Cho · University of Washington6 papers (2018–2024)Stacey B. Whitbourne · Harvard University6 papers (2015–2025)Yuk‐Lam Ho · VA Boston Healthcare System6 papers (2018–2024)J. Michael Gaziano · VA Boston Healthcare System5 papers (2020–2025)Saiju Pyarajan · Harvard University4 papers (2015–2021)J Michael Gaziano · Atlanta VA Health Care System4 papers (2023–2024)Kelly Cho · VA Boston Healthcare System4 papers (2023–2025)John Concato · United States Food and Drug Administration4 papers (2014–2020)David Gagnon · Boston University4 papers (2021–2023) · 3 papers (2014–2020)Tianxi Cai · Harvard University3 papers (2022–2024)Mary T. Brophy · Boston University3 papers (2014–2020) · 3 papers (2022–2024)Andrew Dey · University of Utah3 papers (2023–2024)Brendin Beaulieu-Jones · Riverside University Health System - Medical Center3 papers (2023–2024)Michael O. Francis · Booz Allen Hamilton (United States)3 papers (2024–2026) · 3 papers (2023–2024)Bryan R. Gorman · Massachusetts Department of Public Health3 papers (2024–2026)